Granite Point Mortgage (NYSE:GPMT) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 24.14 percent decrease over earnings of $0.29 per share from the same period last year.
FDA Approves BeiGene’s Brukinsa For Chronic Lymphocytic Leukemia
The FDA has approved BeiGene Ltd’s (NASDAQ:BGNE) Bruton’s tyrosine kinase inhibitor (BTKi) Brukinsa (zanubrutinib) for chronic lymphocytic leukemia (CLL) or small lymphocytic…